SCHEMBL6800580

SCHEMBL6800580

O=c1c2cc(F)c(Cl)cc2n(C2CC2)c(=O)n1OCc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
TSHR P16473 2/20 0.38
PIM1 P11309 3/20 0.38
PIM2 Q9P1W9 1/20 0.38
ALKBH5 Q6P6C2 1/20 0.37
NPSR1 Q6W5P4 2/20 0.36
POLB P06746 1/20 0.36
ALOX15 P16050 1/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
SLC5A2 P31639 1/20 0.36
KCNA5 P22460 1/20 0.35
GRM4 Q14833 1/20 0.35
MTOR P42345 2/20 0.35
PRKDC P78527 2/20 0.35
PIK3CA P42336 1/20 0.35
CYP11B1 P15538 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6799741 0.84 THRB (0.41) ALDH1A1TSHRNPSR1POLBMAPT
SCHEMBL7009095 0.82 TOP1 (0.39) ALDH1A1TSHRNPSR1POLBALOX15
SCHEMBL6801910 0.76 L3MBTL1 (0.37) ALDH1A1TSHRNPSR1POLBMAPT
SCHEMBL6801350 0.76 ALDH1A1 (0.40) ALDH1A1TSHRALOX15TP53MAPT
SCHEMBL6801629 0.75 MAPT (0.41) ALDH1A1TSHRPIM1ALOX15TP53
SCHEMBL6795932 0.73 ALDH1A1 (0.47) ALDH1A1TSHRNPSR1ALOX15GRM4
SCHEMBL6803072 0.73 KMT2A (0.39) TP53MTORPRKDCPIK3CA
SCHEMBL6803077 0.73 KMT2A (0.39) TP53MTORPRKDCPIK3CA
SCHEMBL6796311 0.73 ALDH1A1 (0.41) ALDH1A1TSHRMAPT
SCHEMBL6802031 0.72 TOP1 (0.44) POLBTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1028950-B1 7-SUBSTITUTED QUINAZOLIN-2,4-DIONES USEFUL AS ANTIBACTERIAL AGENTS WARNER LAMBERT CO (US) 2003-05-02 EP claimed
US-20020115674-A1 Novel 7-substituted quinazolin-2,4-diones useful as antibacterial agents DOMAGALA JOHN MICHAEL (US) 2002-08-22 US claimed
US-6825199-B2 7-Substituted quinazolin-2,4-diones useful as antibacterial agents WARNER-LAMBERT COMPANY 2004-11-30 US disclosed
EP-1028950-B1 7-SUBSTITUTED QUINAZOLIN-2,4-DIONES USEFUL AS ANTIBACTERIAL AGENTS WARNER LAMBERT CO (US) 2003-05-02 EP disclosed
US-20020115674-A1 Novel 7-substituted quinazolin-2,4-diones useful as antibacterial agents DOMAGALA JOHN MICHAEL (US) 2002-08-22 US disclosed
US-6331538-B1 TREATMENT OF BACTERIAL INFECTION WARNER-LAMBERT COMPANY 2001-12-18 US disclosed
EP-1028950-A1 NOVEL 7-SUBSTITUTED QUINAZOLIN-2,4-DIONES USEFUL AS ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 2000-08-23 EP disclosed
WO-1999021840-A1 NOVEL 7-SUBSTITUTED QUINAZOLIN-2,4-DIONES USEFUL AS ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 1999-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020115674-A1 Novel 7-substituted quinazolin-2,4-diones useful as antibacterial agents NQO2, TOP1, TOP2A ALDH1A1 3064/4885TSHR 4720/4885PIM1 2808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.